News
IMMVF
3.000
NaN%
--
Immunovia’s PancreaSure Validation Study Published, Bolstering Early Pancreatic Cancer Test
TipRanks · 6d ago
Immunovia Proposes 1:100 Reverse Share Split Ahead of 2026 Meeting
TipRanks · 12/17 16:32
Immunovia AB Announces EGM for Reverse Share Split and Articles Amendment
TipRanks · 12/17 16:32
Immunovia AB Expands Share Count to Bolster Market Position
TipRanks · 11/28 13:32
Immunovia AB’s Earnings Call: Progress and Challenges
TipRanks · 11/28 00:01
Immunovia AB Reports Q3 2025 Earnings and Strategic Progress
TipRanks · 11/27 03:52
Immunovia Secures Medicare Payment Rate for PancreaSure Test
TipRanks · 11/26 15:32
Immunovia AB Reports Successful Launch of PancreaSure Test and Financial Improvements in Q3 2025
TipRanks · 11/26 08:02
Immunovia’s PancreaSure Test Validated in Peer-Reviewed Study
TipRanks · 11/24 13:32
Immunovia to Release Q3 2025 Results and Host Webcast
TipRanks · 11/20 12:32
Immunovia AB Strengthens Capital with Directed Share Issue
TipRanks · 10/29 18:04
Immunovia’s PancreaSure Test Validated in Leading Journal
TipRanks · 10/27 13:32
Immunovia’s PancreaSure Test Data to be Highlighted at ACG 2025 Meeting
TipRanks · 10/27 07:29
Immunovia Secures SEK 100 Million for PancreaSure Launch
TipRanks · 10/23 14:32
Immunovia AB Concludes Trading in Rights Issue Subscription
Barchart · 10/17 02:10
Immunovia’s North Carolina Lab Achieves CAP Accreditation
Barchart · 10/14 07:46
Immunovia Showcases Pancreatic Cancer Surveillance Advances
Barchart · 10/11 02:26
More
Webull provides a variety of real-time IMMVF stock news. You can receive the latest news about Immunovia Ab through multiple platforms. This information may help you make smarter investment decisions.
About IMMVF
Immunovia AB (publ) is a Sweden-based diagnostic company that is developing and commercializing blood tests for the early detection of cancer and autoimmune diseases based on Immunovia’s test platform called IMMray. Tests are based on antibody biomarker microarray analysis using machine-learning and bioinformatics to single-out a set of relevant biomarkers that indicate a certain disease. Thus, forming a disease biomarker signature. Immunovia Dx Laboratories locations in USA and Sweden provides laboratory testing services in two accredited reference laboratories.